Adefovir Dipivoxil: A New Agent For Active Hepatitis B Virus Infection | P&T Community

首页> 外文期刊>P & T: a peer-reviewed journal for formulary management >Adefovir Dipivoxil: A New Agent For Active Hepatitis B Virus Infection | P&T Community

【24h】

Adefovir Dipivoxil: A New Agent For Active Hepatitis B Virus Infection | P&T Community

机译：阿德福韦酯：一种新的活性乙型肝炎病毒感染药物P＆T社区

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《P & T: a peer-reviewed journal for formulary management 》 |2003年第1期| 共页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类药学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Adefovir dipivoxil: a new antiviral agent for the treatment of hepatitis B virus infection. [J] . Qaqish RB, Mattes KA, Ritchie DJ Clinical therapeutics . 2003 ,第12期

机译：阿德福韦酯：一种用于治疗乙型肝炎病毒感染的新型抗病毒药。
2. Low-dose adefovir dipivoxil–induced hypophosphatemia osteomalacia in five chronic hepatitis B virus–infected patients. Is low-dose adefovir dipivoxil–induced nephrotoxicity completely reversible? [J] . Yan-Ying Qian, Zhi-Juan Dai, Lu-Ya Ruan, Drug Design, Development and Therapy . 2019 ,第4期

机译：小剂量阿德福韦酯对5例慢性乙型肝炎病毒感染患者引起的低磷血症性骨软化症。小剂量阿德福韦酯引起的肾毒性是否完全可逆？
3. Efficacy and safety of adefovir dipivoxil 20mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10mg daily. [J] . Hezode C, Chevaliez S, Bouvier-Alias M, Journal of Hepatology: The Journal of the European Association for the Study of the Liver . 2007 ,第5期

机译：每天20mg阿德福韦酯对HBeAg阳性的拉米夫定耐药性乙型肝炎病毒患者的疗效和安全性，对每天10mg阿德福韦酯的次优病毒学应答。
4. Adefovir dipivoxil for the treatment of chronic hepatitis B infection and in vitro evaluation of hte cross-resistance profiles of lamivudine,famciclovir and adefovir [C] . X Xiong, A Murray, H Yang, Second workshop related to HIV/AIDS in China . 1999

机译：阿德福韦酯对慢性乙型肝炎感染的治疗以及拉米夫定，泛昔洛韦和阿德福韦的交叉耐药性的体外评估
5. Active injection drug use and other barriers to management of hepatitis C and human immunodeficiency virus infections [D] . Reed, Carrie 2007

机译：主动注射药物和其他障碍对丙型肝炎和人类免疫缺陷病毒感染的影响
6. Low-dose adefovir dipivoxil–induced hypophosphatemia osteomalacia in five chronic hepatitis B virus–infected patients. Is low-dose adefovir dipivoxil–induced nephrotoxicity completely reversible? [O] . Yan-Ying Qian, Zhi-Juan Dai, Lu-Ya Ruan, 2019

机译：小剂量阿德福韦酯对5例慢性乙型肝炎病毒感染患者引起的低磷血症性骨软化症。小剂量阿德福韦酯引起的肾毒性是否完全可逆？
7. Human Immunodeficiency Virus (HIV) Type 1 Reverse Transcriptase Resistance Mutations in Hepatitis B Virus (HBV)-HIV-Coinfected Patients Treated for HBV Chronic Infection Once Daily with 10 Milligrams of Adefovir Dipivoxil Combined with Lamivudine [O] . Delaugerre, Constance, Marcelin, Anne-Geneviève, Thibault, Vincent, 2002

机译：乙肝病毒（HBV）-HIV合并感染的患者的人类免疫缺陷病毒（HIV）1型逆转录酶抗性突变，每天一次用10毫克阿德福韦酯联合拉米夫定治疗，以治疗HBV慢性感染
8. Guidance for Industry Chronic Hepatitis C Virus Infection: Developing Direct-Acting Antiviral Agents for Treatment [R] . 2010

机译：工业慢性丙型肝炎病毒感染指南：开发直接作用的抗病毒药物进行治疗

Adefovir Dipivoxil: A New Agent For Active Hepatitis B Virus Infection | P&T Community

著录项

相似文献

相关主题

期刊订阅